Insulet Corporation (PODD) Stock Analysis

Sector: HEALTHCARE - MEDICAL DEVICES

Exchange: NASDAQ

Key Metrics

• Price: $251.50
• Market Cap: $17.47B
• P/E Ratio: 71.50
• EPS: $3.47
• 52-Week High: $354.88
• 52-Week Low: $230.05

Market Sentiment

Insulet Corporation currently has a Bullish sentiment score of 0.18.

About Insulet Corporation

Insulet Corporation (PODD) is a pioneering company in the field of insulin delivery systems, dedicated to enhancing the quality of life for individuals with insulin-dependent diabetes through innovative technology. Based in Acton, Massachusetts, Insulet is renowned for its Omnipod® Insulin Management System, a revolutionary tubeless, wearable pump that provides patients with unprecedented flexibility and ease of use. With a robust commitment to advancing diabetes care, Insulet is actively exp...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Insulet Corporation and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does PODD pay dividends?

Insulet Corporation (PODD) does not currently pay a regular dividend.

What is PODD's P/E ratio?

Insulet Corporation has a price-to-earnings (P/E) ratio of 71.50.

What is PODD's market cap?

Insulet Corporation (PODD) has a market capitalization of $17.47B with a current stock price of $251.50.